Pall has acquired 7 companies of its own. It has also divested 2 assets.
Pall’s largest acquisition to date was in 2014, when it acquired ATMI- LifeSciences Business for $185M. It’s largest disclosed sale occurred in 2012, when it sold Pall - Transfusion Medicine Business to Haemonetics for $551M. Pall has acquired in 3 different US states, and 3 countries. The Company’s most targeted sectors include life science (43%) and manufacturing (29%).
Join Mergr and gain access to Pall’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the manufacturing sector.
M&A Total Activity9
- M&A Buy Activity7
- M&A Sell Activity2
- Total Sectors Invested 4
- Total Countries Invested 3
- M&A Buy/Sell Connections 3